Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 71 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3

Molecular tumor board in patients with metastatic breast cancer.
Boscolo Bielo L, Guerini Rocco E, Crimini E, Repetto M, Lombardi M, Zanzottera C, Aurilio G, Barberis M, Belli C, Zhan Y, Battaiotto E, Katrini J, Marsicano R, Zagami P, Taurelli Salimbeni B, Esposito A, Trapani D, Criscitiello C, Fusco N, [...] Curigliano G
Breast Cancer Res Treat, 30 Oct 2024
Cited by: 0 articles | PMID: 39476312
Add to export list
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2<sup>EV</sup> Study.
Fiala O, Massari F, Basso U, Giannatempo P, Grande E, Buti S, Myint ZW, De Giorgi U, Pichler R, Grillone F, Ürün Y, Calabrò F, Bourlon MT, Galli L, Kanesvaran R, Roviello G, Kucharz J, Rizzo M, Park SH, [...] Santoni M
Target Oncol, 19(6):905-915, 01 Oct 2024
Cited by: 0 articles | PMID: 39354179 | PMCID: PMC11557677
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.
Guerrieri-Gonzaga A, Serrano D, Gnagnarella P, Johansson H, Zovato S, Nardi M, Pensabene M, Buccolo S, DeCensi A, Briata IM, Pistelli L, Sansone C, Mannucci S, Aristarco V, Macis D, Lazzeroni M, Aurilio G, Accornero CA, Gandini S, Bonanni B
PLoS One, 19(9):e0309511, 03 Sep 2024
Cited by: 0 articles | PMID: 39226292 | PMCID: PMC11371200
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Massari F, Santoni M, Takeshita H, Okada Y, Tapia JC, Basso U, Maruzzo M, Scagliarini S, Büttner T, Fornarini G, Myint ZW, Galli L, Souza VC, Pichler R, De Giorgi U, Gandur N, Lam ET, Gilbert D, Popovic L, [...] Bellmunt J
Cancer Immunol Immunother, 73(6):106, 18 Apr 2024
Cited by: 2 articles | PMID: 38634928 | PMCID: PMC11026312
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Maiorano BA, Di Maio M, Cerbone L, Maiello E, Procopio G, Roviello G, MeetURO Group
JAMA Netw Open, 7(3):e241215, 04 Mar 2024
Cited by: 2 articles | PMID: 38446479 | PMCID: PMC10918499
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Evolving paradigms in breast cancer screening: Balancing efficacy, personalization, and equity.
Pesapane F, Rotili A, Raimondi S, Aurilio G, Lazzeroni M, Nicosia L, Latronico A, Pizzamiglio M, Cassano E, Gandini S
Eur J Radiol, 172:111321, 17 Jan 2024
Cited by: 3 articles | PMID: 38244317
Add to export list
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Fiala O, Buti S, Takeshita H, Okada Y, Massari F, Palacios GA, Dionese M, Scagliarini S, Büttner T, Fornarini G, Myint ZW, Galli L, Souza VC, Pichler R, De Giorgi U, Quiroga MNG, Gilbert D, Popovic L, Grande E, [...] Santoni M
Cancer Immunol Immunother, 72(11):3665-3682, 07 Sep 2023
Cited by: 8 articles | PMID: 37676282 | PMCID: PMC10992198
Add to export list Free full text in Europe PMC
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Porta C, Bamias A, Zakopoulou R, Myint ZW, Cavasin N, Iacovelli R, Pichler M, Kopecky J, Kucharz J, Rizzo M, Galli L, Büttner T, DE Giorgi U, Kanesvaran R, Fiala O, Grande E, Zucali PA, Kopp RM, Fornarini G, [...] Santoni M
Minerva Urol Nephrol, 75(4):460-470, 01 Aug 2023
Cited by: 2 articles | PMID: 37530662
Add to export list
Image-Guided Ablations in Patients with Recurrent Renal Cell Carcinoma.
Aurilio G, Mauri G, Rossi D, Della Vigna P, Bonomo G, Varano GM, Maiettini D, Rocca MC, Verri E, Cullurà D, Nolé F, Orsi F
J Clin Med, 12(15):4902, 26 Jul 2023
Cited by: 1 article | PMID: 37568303 | PMCID: PMC10420241
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Santoni M, Buti S, Myint ZW, Maruzzo M, Iacovelli R, Pichler M, Kopecky J, Kucharz J, Rizzo M, Galli L, Büttner T, De Giorgi U, Kanesvaran R, Fiala O, Grande E, Zucali PA, Kopp RM, Fornarini G, Bourlon MT, [...] Porta C
Eur Urol Oncol, 7(1):102-111, 21 Jul 2023
Cited by: 13 articles | PMID: 37481365
Add to export list
Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer.
Manna EDF, Serrano D, Aurilio G, Bonanni B, Lazzeroni M
Healthcare (Basel), 11(16):2360, 21 Aug 2023
Cited by: 1 article | PMID: 37628558 | PMCID: PMC10454363
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Santoni M, Massari F, Myint ZW, Iacovelli R, Pichler M, Basso U, Kopecky J, Kucharz J, Buti S, Rizzo M, Galli L, Büttner T, De Giorgi U, Kanesvaran R, Fiala O, Grande E, Zucali PA, Fornarini G, Bourlon MT, [...] Porta C
Target Oncol, 18(4):559-570, 27 Jun 2023
Cited by: 10 articles | PMID: 37369815
Add to export list
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).
Santoni M, Massari F, Myint ZW, Iacovelli R, Pichler M, Basso U, Kopecky J, Kucharz J, Buti S, Salfi A, Büttner T, De Giorgi U, Kanesvaran R, Fiala O, Grande E, Zucali PA, Fornarini G, Bourlon MT, Scagliarini S, [...] Porta C
Clin Genitourin Cancer, 21(5):e309-e319.e1, 20 Mar 2023
Cited by: 8 articles | PMID: 37062658
Add to export list
Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies.
Santoni M, Molina-Cerrillo J, Myint ZW, Massari F, Buchler T, Buti S, Matrana MR, De Giorgi U, Rizzo M, Zabalza IO, Galli L, Zucali PA, Aurilio G, Incorvaia L, Bassanelli M, Mammone G, Salfi A, Isella L, Mollica V, [...] Battelli N
Target Oncol, 17(5):571-581, 10 Aug 2022
Cited by: 5 articles | PMID: 35947324
Add to export list
Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival.
Santoni M, Monteiro FSM, Massari F, Abahssain H, Aurilio G, Molina-Cerrillo J, Myint ZW, Zabalza IO, Battelli N, Grande E
Crit Rev Oncol Hematol, 176:103731, 17 Jun 2022
Cited by: 5 articles | PMID: 35718065
Add to export list Review
Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma.
Santoni M, Massari F, Matrana MR, Basso U, De Giorgi U, Aurilio G, Buti S, Incorvaia L, Rizzo M, Martignetti A, Maslov D, Tawagi K, Philon E, Blake Z, Porta C, Battelli N
Eur J Cancer, 172:191-198, 30 Jun 2022
Cited by: 9 articles | PMID: 35780525
Add to export list
Emerging treatment landscape of non-muscle invasive bladder cancer.
Valenza C, Antonarelli G, Giugliano F, Aurilio G, Verri E, Briganti A, Curigliano G, Necchi A
Expert Opin Biol Ther, 22(6):717-734, 31 May 2022
Cited by: 7 articles | PMID: 35634893
Add to export list Review
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study.
Dieckmann KP, Pokrivcak T, Geczi L, Niehaus D, Dralle-Filiz I, Matthies C, Dienes T, Zschäbitz S, Paffenholz P, Gschliesser T, Pichler R, Mego M, Bader P, Zengerling F, Heinzelbecker J, Krausewitz P, Krege S, Aurilio G, Aksoy C, [...] Pichler M
Ther Adv Med Oncol, 14:17588359221086813, 31 Mar 2022
Cited by: 2 articles | PMID: 35386956 | PMCID: PMC8977693
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison.
Santoni M, Aurilio G, Massari F, Grande E, Matrana MR, Rizzo M, De Giorgi U, Incorvaia L, Martignetti A, Molina-Cerrillo J, Zabalza IO, Mollica V, Rizzo A, Battelli N, Porta C
Clin Genitourin Cancer, 20(3):285-295, 19 Feb 2022
Cited by: 6 articles | PMID: 35305916
Add to export list
Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors.
Santoni M, Massari F, Bracarda S, Grande E, Matrana MR, Rizzo M, De Giorgi U, Basso U, Aurilio G, Incorvaia L, Martignetti A, Molina-Cerrillo J, Mollica V, Rizzo A, Battelli N
Eur Urol Focus, 8(6):1696-1702, 19 Feb 2022
Cited by: 16 articles | PMID: 35193819
Add to export list
First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series.
Buti S, Bersanelli M, Massari F, De Giorgi U, Caffo O, Aurilio G, Basso U, Carteni G, Caserta C, Galli L, Boccardo F, Procopio G, Facchini G, Fornarini G, Berruti A, Fea E, Naglieri E, Petrelli F, Iacovelli R, [...] Mosca A
World J Clin Oncol, 12(11):1037-1046, 01 Nov 2021
Cited by: 2 articles | PMID: 34909398 | PMCID: PMC8641010
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Metabolomic Profiling in Renal Cell Carcinoma Patients: News and Views.
Aurilio G, Santoni M, Massari F, Cimadamore A, Rizzo A, Mollica V, Verri E, Battelli N, Montironi R
Cancers (Basel), 13(20):5229, 18 Oct 2021
Cited by: 8 articles | PMID: 34680377 | PMCID: PMC8534108
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Penile-sparing surgery for patients with superficial or initially invasive squamous cell carcinoma of the penis: long-term oncological outcomes.
Luzzago S, Serino A, Aurilio G, Mistretta FA, Piccinelli ML, Lorusso V, Morelli M, Bianchi R, Catellani M, Cozzi G, Di Trapani E, Cioffi A, Verri E, Ferro M, Cossu Rocca M, Matei DV, Nolè F, de Cobelli O, Musi G
Urol Oncol, 39(10):736.e1-736.e7, 21 Jul 2021
Cited by: 2 articles | PMID: 34301457
Add to export list
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.
Santoni M, Massari F, Grande E, Procopio G, Matrana MR, Rizzo M, De Giorgi U, Basso U, Milella M, Iacovelli R, Aurilio G, Incorvaia L, Buti S, Caffo O, Fornarini G, Carrozza F, Mollica V, Rizzo A, Farag F, [...] Battelli N
Target Oncol, 16(5):625-632, 02 Aug 2021
Cited by: 3 articles | PMID: 34338966
Add to export list
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3).
Seidel C, Daugaard G, Nestler T, Tryakin A, Fedyanin M, Fankhauser CD, Hermanns T, Aparicio J, Heinzelbecker J, Paffenholz P, Heidenreich A, De Giorgi U, Cathomas R, Lorch A, Fingerhut A, Gayer F, Bremmer F, Giannatempo P, Necchi A, [...] Oing C
World J Urol, 39(9):3407-3414, 08 Mar 2021
Cited by: 3 articles | PMID: 33683412 | PMCID: PMC8510898
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 71 results

1 2 3

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Partnerships & funding